Circulating free fetal nucleic acids in maternal plasma and preeclampsia

Medical Hypotheses

Volumn 74, Issue 6, 2010, Pages 1030-1032

  Vlková, Barbora ^a,b   Szemes, Tomáš ^a,b   Minárik, Gabriel ^a,b   Turňa, Ján ^b   Celec, Peter ^a,b  

^a Geneton Inc ^*  (Slovakia)

^b Physics and Informatics   (Slovakia)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR; AUTOANTIBODY; CD8 ANTIGEN; DNA; INTERLEUKIN 6; NUCLEIC ACID; PLASMINOGEN ACTIVATOR INHIBITOR 1; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; RNA; THROMBOPLASTIN; VASCULOTROPIN RECEPTOR;

ARTICLE; AUTOIMMUNITY; CD8+ T LYMPHOCYTE; DISEASE ASSOCIATION; FEMALE; FETUS; HUMAN; HYPOTHESIS; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; MALE; MATERNAL BLOOD; PATHOPHYSIOLOGY; PREECLAMPSIA; PREGNANCY; RISK ASSESSMENT; SEX DIFFERENCE; T LYMPHOCYTE; Y CHROMOSOME;

AUTOIMMUNITY; CHROMOSOMES, HUMAN, Y; FEMALE; FETAL BLOOD; HUMANS; IMMUNE TOLERANCE; IMMUNITY, CELLULAR; MALE; MATERNAL-FETAL EXCHANGE; MODELS, BIOLOGICAL; NUCLEIC ACIDS; PRE-ECLAMPSIA; PREGNANCY; SEX CHARACTERISTICS; TRANSFECTION;

EID: 77951621628     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2010.01.003     Document Type: Article

References (25)

1. Roberts J.M., Redman C.W.G. Preeclampsia - more than pregnancy-induced hypertension. Lancet 1993, 341:1447-1451.
2. Redman C.W., Sargent I.L. Latest advances in understanding preeclampsia. Science 2005, 308:1592-1594.
3. Sibai B., Dekker G., Kupferminc M. Pre-eclampsia. Lancet 2005, 365:785-799.
4. Xia Y., Kellems R.E. Is preeclampsia an autoimmune disease?. Clin Immunol 2009, 133:1-12.
5. Wallukat G., Homuth V., Fischer T., Lindschau C., Horstkamp B., Jupner A., et al. Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT(1) receptor. J Clin Invest 1999, 103:945-952.
6. Lo Y.M.D., Corbetta N., Chamberlain P.F., Rai V., Sargent I.L., Redman C.W.G., et al. Presence of fetal DNA in maternal plasma and serum. Lancet 1997, 350:485-487.
7. Lo Y.M.D., Leung T.N., Tein M.S.C., Sargent I.L., Zhang J., Lau T.K., et al. Quantitative abnormalities of fetal DNA in maternal serum in preeclampsia. Clin Chem 1999, 45:184-188.
8. Engel K., Plonka T., Bilar M., Orzinska A., Brojer E., Ronin-Walknowska E. The correlation between clinical characteristics of preeclampsia and the concentration of fetal DNA in maternal circulation. Eur J Obstet Gynecol Reprod Biol 2008, 139:256-257.
9. Levine R.J., Qian C., LeShane E.S., Yu K.F., England L.J., Schisterman E.F., et al. Two-stage elevation of cell-free fetal DNA in maternal sera before onset of preeclampsia. Am J Obstet Gynecol 2004, 190:707-713.
10. Bischoff F.Z., Lewis D.E., Simpson J.L. Cell-free fetal DNA in maternal blood: kinetics, source and structure. Hum Reprod Update 2005, 11:59-67.
11. Li Y., Zimmermann B., Rusterholz C., Kang A.J., Holzgreve W., Hahn S. Size separation of circulatory DNA in maternal plasma permits ready detection of fetal DNA polymorphisms. Clin Chem 2004, 50:1002-1011.
12. Hristoskova S., Holzgreve W., Hahn S. Anti-phospholipid and anti-DNA antibodies are not associated with the elevated release of circulatory fetal DNA in pregnancies affected by preeclampsia. Hypertens Pregnancy 2004, 23:257-268.
13. Ng E.K.O., Tsui N.B.Y., Lau T.K., Leung T.N., Chiu R.W.K., Panesar N.S., et al. mRNA of placental origin is readily detectable in maternal plasma. Proc Natl Acad Sci USA 2003, 100:4748-4753.
14. Schmidt M., Hoffmann B., Kimmig R., Kasimir-Bauer S. mRNA of placental origin in maternal serum of women with normal and preeclamptic pregnancies. Fetal Diagn Ther 2009, 25:269-276.
15. Pang W.W.I., Tsui M.H.Y., Sahota D., Leung T.Y., Lau T.K., Lo Y.M.D., et al. A strategy for identifying circulating placental RNA markers for fetal growth assessment. Prenat Diag 2009, 29:495-504.
16. Purwosunu Y., Sekizawa A., Okazaki S., Farina A., Wibowo N., Nakamura M., et al. Prediction of preeclampsia by analysis of cell-free messenger RNA in maternal plasma. Am J Obstet Gynecol 2009, 200.
17. Wong B.C.K., Lo Y.M.D. Plasma RNA integrity analysis - methodology and validation. 4th international symposium on circulating nucleic acids in plasma/serum 2005, 174-178. Blackwell Publishing, London, England. R. Swaminathan, A. Butt, P. Gahan (Eds.).
18. Hasselmann D.O., Rappl G., Tilgen W., Reinhold U. Extracellular tyrosinase mRNA within apoptotic bodies is protected from degradation in human serum. Clin Chem 2001, 47:1488-1489.
19. Ingemarsson I. Gender aspects of preterm birth. In: 1st international preterm labour congress. Montreux, Switzerland: Elsevier Science, Amsterdam, Netherlands I; 2002. p. 34-8.
20. Sheiner E., Levy A., Katz M., Hershkovitz R., Leron E., Mazor M. Gender does matter in perinatal medicine. Fetal Diagn Ther 2004, 19:366-369.
21. Di Renzo G.C., Rosati A., Sarti R.D., Cruciani L., Cutuli A.M. Does fetal sex affect pregnancy outcome?. Gender Med 2007, 4:19-30.
22. Stark M.J., Clifton V.L., Wright I.M.R. Neonates born to mothers with preeclampsia exhibit sex-specific alterations in microvascular function. Pediatr Res 2009, 65:291-295.
23. Stark M.J., Dierkx L., Clifton V.L., Wright I.M.R. Alterations in the maternal peripheral microvascular response in pregnancies complicated by preeclampsia and the impact of fetal sex. J Soc Gynecol Invest 2006, 13:573-578.
24. Piper K.P., McLarnon A., Arrazi J., Horlock C., Ainsworth J., Kilby M.D., et al. Functional HY-specific CD8(+) T cells are found in a high proportion of women following pregnancy with a male fetus. Biol Reprod 2007, 76:96-101.
25. Zhong X.Y., Hahn S., Steinborn A., Holzgreve W. Quantitative analysis of intact fetal cells in maternal plasma by real-time PCR. Eur J Obstet Gynecol Reprod Biol 2007, 133:20-24.